The toluidine red unheated serum test (TRUST) antigen, a macroscopic flocculation test antigen developed by Pettit et al. (J. Clin. Microbiol. 18:1141-1145 , 1983 ) by modifying the color-coded antigen of Kasatiya and Lambert (Appl. Microbiol. 28:317-318, 1974) 
In 1974, Kasatiya and Lambert (2) reported on the use of a color-coded antigen in the automated reagin test for syphilis. Recently, this antigen was modified by Pettit et al. (3) for use in an 18-mm circle card macroscopic test to satisfy the need for a flocculation test that is inexpensive and easy to perform and produces results comparable to those with the Venereal Disease Research Laboratory (VDRL) slide and rapid plasma reagin (RPR) card tests for screening and serodiagnosis of syphilis.
The modified version of the color-coded antigen test, the toluidine red unheated serum test (TRUST), uses an antigen prepared from VDRL antigen suspension. A 0.25% toluidine red pigment suspension is added as a visualizing agent. This red pigment allows the antigen-antibody reaction to x 100 (1). In laboratory 1, the sensitivity of the TRUST and the VDRL slide test was 100% on serum samples from untreated patients and 91 and 95%, respectively, on serum samples from treated patients. In laboratory 2, the sensitivity of the TRUST and the VDRL slide test was the same on serum samples from untreated and treated patients at 97 and 85%, respectively. The average sensitivity of the TRUST and the VDRL slide test was 98.7% for both on untreated patients and 88.2 and 90%, respectively, on serum samples from treated patients. The TRUST was as sensitive as the VDRL slide and the RPR card tests on serum samples from untreated and treated patients in the secondary stage of syphilis. It was as sensitive as the VDRL slide test and more sensitive than the RPR card test on serum samples from untreated patients, regardless of stages of syphilis. It was less sensitive than the VDRL slide test and slightly more sensitive than the RPR card test on serum samples from treated syphilitic patients, regardless of stages. The specificity of each test was based on results obtained on 1,024 nonsyphilitic serum samples ( (3) .
